Organon to Release Third Quarter 2026 Financial Results via Form 10-Q Filing

Organon (NYSE: OGN), a global healthcare company, announced on October 19, 2026, its plan to release its third quarter 2026 financial results through its regularly scheduled Form 10-Q filing with the Securities and Exchange Commission (SEC). The company will also disclose certain non-GAAP financial measures and their reconciliation in a Form 8-K filing on the same day. Organon has suspended its quarterly earnings calls during the pendency of its previously announced acquisition by Sun Pharmaceutical Industries Limited.